Is SYBLEU Inc halal to invest in?

According to Musaffa's Shariah screening methodology, SYBLEU Inc (SYBE) is currently classified as NOT COVERED as of May 2026. The classification is based on an evaluation of the company's business activities and financial ratios to determine whether it meets Islamic investment guidelines.

Is SYBLEU Inc a Shariah-compliant stock?

A stock is Shariah-compliant if the company operates in permissible business activities and meets Islamic financial screening thresholds. Musaffa analyzes SYBLEU Inc using these criteria to determine its compliance status.

Can Muslims buy shares of SYBLEU Inc?

Muslim investors may consider investing in SYBLEU Inc if it meets Shariah compliance standards. Investors typically review the company's business activities, debt levels, and non-permissible income before making a decision.

Why is SYBLEU Inc classified as NOT COVERED?

Musaffa determines the Shariah status of SYBLEU Inc by analyzing whether the company's core business operations are permissible and whether its financial ratios fall within accepted Islamic thresholds.

How often is the Shariah compliance for SYBLEU Inc updated?

The Shariah compliance status of SYBLEU Inc may be updated periodically when new financial statements, earnings reports, or business activity information become available.

Can a halal stock like SYBLEU Inc become non-compliant?

Yes. A stock that is currently Shariah-compliant may become non-compliant if the company's financial ratios exceed Shariah thresholds or its business activities change.

Where can I check the Shariah status of SYBLEU Inc?

You can check the latest Shariah compliance status of SYBLEU Inc on Musaffa's stock page, where screening results and key financial indicators are updated to help Muslim investors make informed decisions.

SYBLEU Inc. Stock Analysis SYBE

United States N/A Nano Cap

SYBLEU, Inc. intends to engage in the development of regenerative medical applications. The company is headquartered in Bronx, New York. The company went IPO on 2023-03-09. The firm is focused on developing therapies for human and animal health, medical devices, and clinical diagnostics. The firm is also developing drugs for treating cancer in companion animals and examining the role of artificial intelligence and machine learning in clinical diagnostics. The company is also involved in the development of disposable medical devices. The firm has completed Phase I and or Phase II clinical trials, after which the Company would either attempt to sell or license those developed applications or, alternatively, advance the application further to Phase III clinical trials.

Key Statistics of SYBLEU Inc (SYBE)

Key statistics in the stock market are essential financial indicators that measure a company's performance, valuation, profitability, and risk.

Today's Range

$0.06$0.06

Today's Open

$0.06

Volume

P/E Ratio (TTM)

Market Cap

5.47M

Avg. Volume

Dividend Yield

Financial Metrics & Statements of SYBLEU Inc (SYBE)

FAQ's for SYBLEU Inc (SYBE)

According to Musaffa’s Shariah screening methodology, SYBLEU Inc (SYBE) is currently classified as NOT COVERED as of May 2026. The classification is based on an evaluation of the company’s business activities and financial ratios to determine whether it meets Islamic investment guidelines.